REVA Medical, Inc. (ASX:RVA) ("REVA" or the "Company") is pleased to announce that its Chief Operating Officer, Robert K. Schultz, PhD, is presenting at the Cardiovascular Research Technologies Conference at 2:25 p.m. US EST on Monday, February 25, 2013. The conference is being held February 23 through 26, 2013, at the Omni Shoreham Hotel in Washington, DC.

A copy of the presentation materials will be available on REVA's website at www.revamedical.com shortly before the presentation.

About REVA

REVA is a development stage medical device company incorporated in Delaware, USA, that is focused on the development and eventual commercialization of its proprietary bioresorbable stent products. REVA's initial product, the ReZolveĀ® scaffold, which is in a clinical study phase, combines REVA's proprietary stent design with a proprietary polymer that is metabolized and cleared from the body. The ReZolve scaffold is designed to offer full x-ray visibility, clinically relevant sizing, and a controlled and safe resorption rate. In addition, by early encapsulation of the stent in the artery tissue coupled with the loss of scaffold structure over time, the ReZolve scaffold may reduce the incidence of late forming blood clots or otherwise reduce long-term disease progression, potential benefits of bioresorbable scaffolds that have yet to be proven. REVA will require clinical results and regulatory approval before it can begin selling the ReZolve scaffold.

The REVA Medical, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8505

CONTACT: United States
         Investor and Media Enquiries:
         Cheryl Liberatore
         Director, Investor Relations and Marketing
         REVA Medical, Inc.
         +1 858 966-3045
         
         Australia
         Investor Enquiries:
         Kim Jacobs or Alan Taylor
         Inteq Limited
         +61 2 9231 3322
         
         Media Enquiries:
         Haley Price or Rebecca Wilson
         Buchan Consulting
         +61 3 9866 4722
Reva Medical (ASX:RVA)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more Reva Medical Charts.
Reva Medical (ASX:RVA)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more Reva Medical Charts.